Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,574 | 74 | 86.2% |
| Gift | $126.63 | 2 | 6.9% |
| Travel and Lodging | $124.66 | 1 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Centinel Spine, LLC | $229.27 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $181.63 | 10 | $0 (2024) |
| Braintree Laboratories, Inc. | $176.58 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $172.85 | 8 | $0 (2024) |
| Davol Inc. | $126.27 | 2 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $124.85 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $110.70 | 4 | $0 (2024) |
| Ardelyx, Inc. | $99.81 | 4 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $57.16 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $54.05 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $753.42 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($149.97) |
| 2023 | $124.33 | 7 | Ironwood Pharmaceuticals, Inc ($29.20) |
| 2021 | $356.94 | 6 | Centinel Spine, LLC ($229.27) |
| 2020 | $90.96 | 4 | Braintree Laboratories, Inc. ($53.32) |
| 2019 | $141.49 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($69.46) |
| 2018 | $225.46 | 10 | DAVOL INC. ($108.98) |
| 2017 | $132.44 | 10 | Takeda Pharmaceuticals America, Inc. ($22.30) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $40.32 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: GI | ||||||
| 09/18/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: CRITICAL CARE | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Immunology | ||||||
| 06/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/31/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/14/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: GI COLON PREP | ||||||
| 05/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Immunology | ||||||
| 04/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/15/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Gastroenterology | ||||||
| 04/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.28 | General |
| Category: Immunology | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 223 | 228 | $71,575 | $24,272 |
| 2022 | 7 | 199 | 211 | $49,565 | $21,210 |
| 2021 | 8 | 202 | 215 | $49,873 | $22,025 |
| 2020 | 9 | 243 | 249 | $93,975 | $23,911 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 38 | $20,825 | $7,480 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $18,510 | $6,700 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 25 | $4,590 | $2,163 | 47.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 12 | $5,260 | $1,923 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $3,915 | $1,923 | 49.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $11,550 | $1,678 | 14.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,340 | $1,653 | 31.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,345 | $642.75 | 47.8% |
| 15853 | Removal of sutures or staples | Office | 2023 | 13 | 13 | $240.00 | $109.46 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $18,240 | $6,719 | 36.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 19 | 19 | $7,600 | $3,760 | 49.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 17 | 17 | $6,970 | $2,866 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $5,280 | $2,834 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $4,140 | $2,263 | 54.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $5,040 | $1,679 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 27 | $2,295 | $1,090 | 47.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $15,040 | $5,454 | 36.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 21 | 21 | $8,610 | $3,846 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 47 | $5,640 | $3,104 | 55.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 14 | 14 | $5,740 | $2,568 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 28 | $5,040 | $2,480 | 49.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $3,058 | $1,893 | 61.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $4,620 | $1,671 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 25 | $2,125 | $1,009 | 47.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 28 | 28 | $29,200 | $5,618 | 19.2% |
About Dr. Christopher Evans, DO
Dr. Christopher Evans, DO is a Surgery healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063401263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Evans, DO has received a total of $1,825 in payments from pharmaceutical and medical device companies, with $753.42 received in 2024. These payments were reported across 77 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,574).
As a Medicare-enrolled provider, Evans has provided services to 867 Medicare beneficiaries, totaling 903 services with total Medicare billing of $91,417. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location York, PA
- Active Since 10/19/2005
- Last Updated 06/30/2025
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063401263
Products in Payments
- STALIF M (Device) $229.27
- XIFAXAN (Drug) $181.63
- VOQUEZNA (Drug) $124.85
- VENTRALIGHT (Device) $108.98
- ENTYVIO (Biological) $103.81
- IBSRELA (Drug) $99.81
- DUPIXENT (Biological) $81.00
- SUTAB (Drug) $73.31
- TREMFYA (Drug) $65.38
- Linzess (Drug) $57.16
- Vascepa (Drug) $54.05
- SUPREP BOWEL PREP (Drug) $53.32
- EOHILIA (Drug) $46.16
- STELARA (Biological) $45.32
- TRELEGY ELLIPTA (Drug) $39.38
- ENTRESTO (Drug) $36.13
- SUFLAVE (Drug) $35.92
- ZENPEP (Drug) $30.14
- TERLIVAZ (Drug) $25.06
- PNEUMOVAX 23 (Biological) $24.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in York
Dr. Joshua Hazelton, D.o, D.O
Surgery — Payments: $270,150
Dr. Faiz Shariff, M.d, M.D
Surgery — Payments: $58,498
Eric Glendinning, Md, MD
Surgery — Payments: $15,688
Martin Asplund, M.d, M.D
Surgery — Payments: $14,211
Annis Ali, Md, MD
Surgery — Payments: $13,170
Dr. Benjamin Vabi, M.d, M.D
Surgery — Payments: $10,207